A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine
Author:
Funder
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-38130-0.pdf
Reference52 articles.
1. Waring, M. J. et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nature reviews. Drug discovery 14, 475–486, https://doi.org/10.1038/nrd4609 (2015).
2. Kaitin, K. I. Deconstructing the drug development process: the new face of innovation. Clinical pharmacology and therapeutics 87, 356–361, https://doi.org/10.1038/clpt.2009.293 (2010).
3. DiMasi, J. A., Grabowski, H. G. & Hansen, R. W. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of health economics 47, 20–33, https://doi.org/10.1016/j.jhealeco.2016.01.012 (2016).
4. DiMasi, J. A., Feldman, L., Seckler, A. & Wilson, A. Trends in risks associated with new drug development: success rates for investigational drugs. Clinical pharmacology and therapeutics 87, 272–277, https://doi.org/10.1038/clpt.2009.295 (2010).
5. Taylor, K., Gordon, N., Langley, G. & Higgins, W. Estimates for worldwide laboratory animal use in 2005. Alternatives to laboratory animals: ATLA 36, 327–342 (2008).
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy;Molecular Cancer;2023-11-28
2. Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues;International Journal of Molecular Sciences;2023-11-14
3. Label-free drug response evaluation of human derived tumor spheroids using three-dimensional dynamic optical coherence tomography;Scientific Reports;2023-09-16
4. The Temozolomide-Doxorubicin paradox in Glioblastoma in vitro-in silico preclinical drug-screening;2023-08-21
5. Application of three-dimensional cell culture technology in screening anticancer drugs;Biotechnology Letters;2023-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3